Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of ...

The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Russia cancer vaccine could receive approval by August allowing treatment to begin the head of the Gamaleya Research ...

BioNTech SE (NASDAQ:BNTX), a biotechnology company renowned for its mRNA technology platform and COVID-19 vaccine success, is navigating a crucial phase in its evolution. With a market capitalization ...

Arcturus Therapeutics Holdings Inc. stock is down 46% since Sept. 2023 coverage; mRNA sector faces headwinds with public ...

This groundbreaking development may enable treatments for inflammatory diseases such as Crohn's and colitis.Researchers at ...

The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.

This SPA agreement marks an important milestone in the development of Descartes-08 for MG, providing critical regulatory clarity and a clear path toward potential approval,” said Carsten Brunn, Ph.D., ...

The measure would seem a premptive strike at a growing industry. No food engineered to include vaccines are approved for use ...

Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking ...

But election vote tallies don't tell the whole story. Trump 2.0 is a manifestation of monumental changes in American ...